ANDREWS WILLIAM T. (Chief Medical Officer) exercised options at CATALYST PHARMACEUTICALS, INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 6/5/2026ACC: 0001161697-26-000132
Officer· Chief Medical Officer
Since Jun 2025
-743.00
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
3
Total transactions
3.05K acquired · 3.79K disposed
Non-Derivative Transactions2
Common Stock, par value $0.001 per share
Direct
Shares
+3.05K
Price / share
—
Trade value
—
% of position
New position
6/3/2026
0.00→3.05K
Common Stock, par value $0.001 per share
Direct
Shares
−743.00
Price / share
—
Trade value
—
% of position
24.3%
6/3/2026
3.05K→2.31K
Total
Net shares
+2.31K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.001 per share Direct | 6/3/2026 | M · Option Exercise | +3.05K | — | — | New position | 0.00 | 3.05K |
| Common Stock, par value $0.001 per share Direct | 6/3/2026 | F · Tax Withholding | −743.00 | — | — | 24.3% | 3.05K | 2.31K |
| Total | +2.31K | $0.00 | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
3.05K shares
Shares
−3.05K
Strike price
Held after
240.19K
Exercisable
—
6/3/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock3.05K shares | 6/3/2025 | M · Option Exercise | −3.05K | — | 240.19K |